BWLSA
ADPT icon

Blue Water Life Science Advisors’s Adaptive Biotechnologies ADPT Stock Holding History

Blue Water Life Science Advisors’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.7M Hold
1,010,145
– – 13.65% 4
2026
Q1 		$14M Sell
1,010,145
-755,000
-43% -$12M 11.24% 4
2025
Q4 		$28.7M Sell
1,765,145
-380,000
-18% -$6.2M 17.99% 3
2025
Q3 		$32.1M Hold
2,145,145
– – 29.28% 1
2025
Q2 		$25M Hold
2,145,145
– – 19.78% 2
2025
Q1 		$15.9M Hold
2,145,145
– – 15.79% 3
2024
Q4 		$12.9M Hold
2,145,145
– – 11.39% 4
2024
Q3 		$11M Buy
+2,145,145
New +$9.35M 9.66% 5
2024
Q2 		– Sell
-1,687,665
Closed -$5.42M – 9
2024
Q1 		$5.42M Hold
1,687,665
– – 5.1% 6
2023
Q4 		$8.27M Sell
1,687,665
-690,000
-29% -$3.15M 7.24% 7
2023
Q3 		$13M Sell
2,377,665
-652,769
-22% -$4.32M 12.23% 4
2023
Q2 		$20.3M Hold
3,030,434
– – 13.72% 4
2023
Q1 		$26.8M Hold
3,030,434
– – 17.69% 2
2022
Q4 		$23.2M Sell
3,030,434
-570,000
-16% -$4.43M 15.55% 3
2022
Q3 		$25.6M Buy
3,600,434
+480,000
+15% +$4.52M 10.35% 5
2022
Q2 		$25.2M Buy
+3,120,434
New +$27.4M 13.71% 4
2021
Q2 		– Sell
-251,695
Closed -$10.1M – 24
2021
Q1 		$10.1M Buy
251,695
+43,595
+21% +$2.36M 4.95% 7
2020
Q4 		$12.3M Buy
+208,100
New +$10.7M 7.22% 6

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Blue Water Life Science Advisors's ADPT Position: Q2 2026 in Review

Blue Water Life Science Advisors held its Adaptive Biotechnologies (ADPT) position steady in Q2 2026 at 1,010,145 shares worth $21.7M. The position accounts for 13.65% of the portfolio, ranked #4.

Blue Water Life Science Advisors first reported a position in ADPT in Q4 2020 and has held it in 18 quarters since. The position peaked at $32.1M in Q3 2025. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Blue Water Life Science Advisors held 1,010,145 shares of Adaptive Biotechnologies worth $21.7M as of Q2 2026.
  • Blue Water Life Science Advisors left its Adaptive Biotechnologies share count unchanged in Q2 2026.
  • Adaptive Biotechnologies made up 13.65% of Blue Water Life Science Advisors's portfolio in Q2 2026, its #4 holding.
  • Blue Water Life Science Advisors first reported a position in Adaptive Biotechnologies in Q4 2020 and has held it in 18 quarters since.
  • Blue Water Life Science Advisors's Adaptive Biotechnologies position peaked at $32.1M in Q3 2025.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Blue Water Life Science Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.